Rudolf Staudigl
CIK: 0002124147
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BNTX
BioNTech SE
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Staudigl Rudolf
Staudigl Rudolf (SEC CIK 0002124147) files insider reports with the SEC as Director of BioNTech SE (BNTX).
Signal8 holds 1 ownership filing by Staudigl Rudolf, a Form 3, filed on Mar 25, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Staudigl Rudolf's filings is in MAINZ.
Other insiders filing for BioNTech SE (BNTX)
- Sahin Ugur, Chief Executive Officer
- Low-Friedrich Iris Katharina, Director
- Schaffert Susanne, Director
- Zapata Gomez Ramon, Chief Financial Officer
- Ryan James Timothy Patrick
- Poetting Sierk, Chief Operating Officer